AUTHOREA
Log in Sign Up Browse Preprints

loading page

Treatment of refractory thrombotic thrombocytopenic purpura with Caplacizumab : A case report
  • +2
  • zakaria maat,
  • lana awad,
  • Mhd Baraa Habib,
  • Abdul Aziz Zafar. ,
  • afaf albattah
zakaria maat
Hamad Medical Corporation

Corresponding Author:zmaat@hamad.qa

Author Profile
lana awad
Hamad Medical Corporation
Author Profile
Mhd Baraa Habib
Hamad Medical Corporation
Author Profile
Abdul Aziz Zafar.
Hamad General Hospital
Author Profile
afaf albattah
Hamad Medical Corporation
Author Profile

Abstract

Caplacizumab can be used as a treatment for TTP refractory to plasmapheresis and steroid

Peer review status:IN REVISION

03 Sep 2021Submitted to Clinical Case Reports
Show details
Hide details
05 Oct 2021Submission Checks Completed
05 Oct 2021Assigned to Editor
14 Oct 2021Reviewer(s) Assigned
24 Oct 2021Review(s) Completed, Editorial Evaluation Pending
24 Oct 2021Editorial Decision: Revise Minor
23 Dec 20211st Revision Received